Hebei Changshan Biochem Pharma (300255) — Free Cash Flow Generation Index
Hebei Changshan Biochem Pharma (300255) has a Free Cash Flow Generation Index of 0.73x as of June 2025. Free cash flow of CN¥51.58 Million represents 1% of operating cash flow (CN¥70.22 Million). Read Hebei Changshan Biochem Pharma total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hebei Changshan Biochem Pharma Free Cash Flow Generation Index (2009–2024)
Historical FCF Generation Index trend for Hebei Changshan Biochem Pharma across 10 annual periods. Explore Hebei Changshan Biochem Pharma (300255) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Hebei Changshan Biochem Pharma (2009–2024)
Year-by-year Free Cash Flow Generation Index for Hebei Changshan Biochem Pharma. For the full company profile including market capitalisation, see market cap of Hebei Changshan Biochem Pharma.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.26x | CN¥-183.37 Million | CN¥56.22 Million | CN¥239.59 Million | ▲ +46.5% |
| 2023 | -6.10x | CN¥-205.60 Million | CN¥33.73 Million | CN¥239.32 Million | ▲ +95.5% |
| 2022 | -136.97x | CN¥-428.10 Million | CN¥3.13 Million | CN¥431.22 Million | ▼ -28.9% |
| 2021 | -106.29x | CN¥-305.21 Million | CN¥2.87 Million | CN¥308.08 Million | ▼ -53794.8% |
| 2018 | 0.20x | CN¥57.96 Million | CN¥292.81 Million | CN¥234.85 Million | ▲ +707.9% |
| 2017 | 0.02x | CN¥3.98 Million | CN¥162.28 Million | CN¥158.30 Million | ▼ -94.4% |
| 2016 | 0.44x | CN¥75.44 Million | CN¥171.96 Million | CN¥96.52 Million | ▲ +155.9% |
| 2011 | -0.79x | CN¥-13.38 Million | CN¥17.04 Million | CN¥30.43 Million | ▼ -176.3% |
| 2010 | -0.28x | CN¥-8.31 Million | CN¥29.25 Million | CN¥37.56 Million | ▼ -4424.2% |
| 2009 | 0.01x | CN¥159.12K | CN¥24.21 Million | CN¥24.05 Million | — |